Abstract |
Pseudolaric acid B is a major compound found in the bark of Pseudolarix kaempferi Gordon. In our study, pseudolaric acid B inhibited growth of human melanoma cells, A375-S2 in a time- and dose-dependent manner. A375-S2 cells treated with pseudolaric acid B showed typical characteristics of apoptosis including morphologic changes, DNA fragmentation, sub-diploid peak in flow cytometry, cleavage of poly-ADP ribose polymerase (PARP) and degradation of inhibitor of caspase-activated DNase (ICAD). P53 protein expression was upregulated while cells were arrested at the G2/M phase of the cell cycle. There was a decrease in the expression of anti-apoptotic Bcl-2 and Bcl-xL proteins, whereas pro-apoptotic Bax was increased. The two classical caspase substrates, PARP and ICAD, were both decreased in a time-dependent manner, indicating the activation of downstream caspases.
|
Authors | Xian-Feng Gong, Min-Wei Wang, Shin-Ichi Tashiro, Satoshi Onodera, Takashi Ikejima |
Journal | Archives of pharmacal research
(Arch Pharm Res)
Vol. 28
Issue 1
Pg. 68-72
(Jan 2005)
ISSN: 0253-6269 [Print] Korea (South) |
PMID | 15742811
(Publication Type: Comparative Study, Journal Article)
|
Chemical References |
- BAX protein, human
- Diterpenes
- Growth Inhibitors
- Proto-Oncogene Proteins c-bcl-2
- Tumor Suppressor Protein p53
- bcl-2-Associated X Protein
- pseudolaric acid B
|
Topics |
- Apoptosis
(drug effects, physiology)
- Cell Line, Tumor
- Diterpenes
(pharmacology)
- Dose-Response Relationship, Drug
- Growth Inhibitors
(pharmacology)
- Humans
- Melanoma
(genetics, metabolism, pathology)
- Proto-Oncogene Proteins c-bcl-2
(biosynthesis, genetics, physiology)
- Signal Transduction
(drug effects, physiology)
- Tumor Suppressor Protein p53
(biosynthesis, genetics)
- bcl-2-Associated X Protein
|